Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4<sup>+</sup>Foxp3<sup>+</sup> Regulatory T Cell Immunosuppression.

Int J Drug Discov Pharm · 2024 · PMC11804271 · PMID 39926714

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The diverse functions of ICPs and their tissue expression profiles may be significant for CVDs and cerebrovascular diseases.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.